Summary: Understanding and Research of PLS Act - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate research and other activities with respect to primary lateral sclerosis.

understanding research act_-_amends public_health_service_act require director national_institutes_of_health nih expand intensify coordinate research activities respect primary lateral sclerosis


Summary: Stem Cell Research Improvement Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements.Requires the Director of the National Institutes of Health (NIH) to issue guidelines on research involving human embryonic stem cells. Authorizes the Director to issue guidelines on research involving other human stem cells, as scientifically warranted. Provides for updates of guidelines under this Act. Directs the Secretary to take into consideration guidelines on human stem cell research developed by nationally- and internationally- recognized scientific organizations.Requires NIH research to comply with guidelines under this Act.Requires the Director to: (1) determine the extent to which the guidelines under this Act apply to research on human embryonic stem cells derived before the effective date of such guidelines; and (2) include in its biennial report to Congress a summary of research activities on human stem cells.

stem cell research improvement act amends public_health_service_act require secretary health_and_human_services conduct support research utilizes human stem cells regardless date stem cells derived human embryo limits research stem cells meet following requirements stem cells derived human donated vitro fertilization clinics created purposes fertility treatment excess needs individuals seeking treatment prior donation determined implanted woman individuals seeking fertility treatment donated written informed consent received financial inducements requires director national_institutes_of_health nih issue guidelines research involving human stem cells authorizes director issue guidelines research involving human stem cells scientifically warranted provides updates guidelines act directs secretary consideration guidelines human stem cell research developed recognized scientific organizations requires nih research comply guidelines act requires director determine extent guidelines act apply research human stem cells derived effective date guidelines include biennial report congress summary research activities human stem cells


Summary: Stem Cell Research Enhancement Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements.

stem cell research enhancement_act amends public_health_service_act require secretary health_and_human_services conduct support research utilizes human stem cells regardless date stem cells derived human embryo limits research stem cells meet following requirements stem cells derived human donated vitro fertilization clinics created purposes fertility treatment excess needs individuals seeking treatment prior donation determined implanted woman individuals seeking fertility treatment donated written informed consent received financial inducements


Summary: Patients First Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act. Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; (2) is prioritized in terms of potential for near-term clinical benefit in human patients; and (3) may take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.Requires the Secretary to: (1) report on peer reviewed stem cell research proposals that were not funded; and (2) study and submit recommendations to Congress on any structural changes to the C.W. Bill Young Cell Transplantation Program that would help to expand access to new and future stem cell therapeutic products.

patients act amends public_health_service_act require secretary health_and_human_services conduct support basic applied research develop techniques isolation production testing human clinical use stem cells result improved understanding treatments diseases adverse health conditions including stem cells flexibility stem cells stem cells source provided techniques involve creation human embryo research purposes destruction risk injury living human embryo use stem cell provision inconsistent act requires secretary issue guidelines implementing act ensure research including clinical trial supported act clearly consistent standards established act conducted human cells prioritized terms potential near term clinical benefit human patients account techniques outlined president council appropriate techniques research requires secretary report peer reviewed stem cell research proposals funded study submit recommendations congress structural changes bill young cell transplantation program help expand access new future stem cell therapeutic products


Summary: Access to America's Orthopaedic Services Act of 2009 - Requires the Secretary of Health and Human Services to establish criteria for accounting and reporting the effort expended by researchers on musculoskeletal research funded with certain grants.Sets forth reporting requirements related to musculoskeletal health, including on: (1) research funded by the National Institutes of Health (NIH); (2) federal programs and activities relating to musculoskeletal trauma care; (3) a standard unit for the measurement of bone mass under the Medicare program; (4) access to orthopaedic services by certain federal health program beneficiaries; and (5) childhood musculoskeletal diseases, conditions, and injuries in the United States.Amends the Public Health Service Act to require the Organ Procurement and Transplantation Network to establish the Transplantation Transmission Sentinel Network to track disease transmission from organ, tissue, or eye transplants.Requires the Secretary to issue regulations relating to the accreditation of: (1) establishments engaged in the manufacture of human cells, tissues, and cellular and tissue-based products; and (2) personnel who participate in related activities.Requires the Secretary to conduct studies related to: (1) a national registry of artificial joint replacements in Medicare beneficiaries; (2) severe trauma to extremities resulting from motor vehicle crashes; (3) workplace-related musculoskeletal injuries and conditions; (4) funding available for graduate medical education in orthopaedics; (5) methods for measuring bone mass in Medicare beneficiaries; and (6) aging in the United States.Requires the Secretary to: (1) conduct a national public awareness program on musculoskeletal health; and (2) award grants for certain health and aging activities for seniors.Provides for musculoskeletal diseases and conditions to be treated as a priority within the Office of Minority Health.

access america services act requires secretary health_and_human_services establish criteria accounting reporting effort expended researchers musculoskeletal research funded certain grants sets forth reporting requirements related musculoskeletal health including research funded national_institutes_of_health nih federal programs activities relating musculoskeletal trauma care standard unit measurement bone mass medicare program access services certain federal health program beneficiaries childhood musculoskeletal diseases conditions injuries united_states amends public_health_service_act require organ procurement transplantation network establish transplantation transmission network track disease transmission organ tissue eye requires secretary issue regulations relating accreditation establishments engaged manufacture human cells tissues cellular tissue based products personnel participate related activities requires secretary conduct studies related national_registry artificial joint replacements medicare beneficiaries severe trauma resulting motor vehicle crashes workplace related musculoskeletal injuries conditions funding available graduate medical education methods measuring bone mass medicare beneficiaries aging united_states requires secretary conduct national public awareness program musculoskeletal health award grants certain health aging activities seniors provides musculoskeletal diseases conditions treated priority office_of_minority_health


Summary: Tom Lantos Pulmonary Hypertension Research and Education Act of 2009 - Expresses the sense of Congress that: (1) the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Heart, Lung, and Blood Institute, should continue aggressive work on pulmonary hypertension; and (2) the Director of the Institute should continue research to expand the understanding of the causes of, and to find a cure for, pulmonary hypertension. Requires inclusion of information on the status of pulmonary hypertension research at NIH in biennial reports to Congress. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of pulmonary hypertension, which may include information on: (1) pulmonary hypertension and its symptoms; (2) the incidence and prevalence of pulmonary hypertension; (3) diseases and conditions that can lead to pulmonary hypertension as a secondary diagnosis; (4) the importance of early diagnosis; and (5) the availability of a range of treatment options. Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to carry out an educational campaign to increase awareness of pulmonary hypertension among health care providers, which may include information on: (1) the symptoms of pulmonary hypertension; (2) the importance of early diagnosis; (3) current diagnostic criteria; and (4) Food and Drug Administration (FDA)-approved therapies for the disease. Requires such campaign to target health care providers, including cardiologists, pulmonologists, rheumatologists, primary care physicians, pediatricians, and nurse practitioners.

tom_lantos pulmonary hypertension research education act expresses sense congress secretary health_and_human_services acting director national_institutes_of_health nih director national_heart lung blood_institute continue aggressive work pulmonary hypertension director institute continue research expand understanding causes find cure pulmonary hypertension requires inclusion information status pulmonary hypertension research nih biennial reports congress requires secretary acting director centers_for_disease_control_and_prevention cdc carry educational campaign increase public awareness pulmonary hypertension include information pulmonary hypertension symptoms incidence prevalence pulmonary hypertension diseases conditions lead pulmonary hypertension secondary diagnosis importance early diagnosis availability range treatment options requires secretary acting administrator health_resources_and_services_administration hrsa director cdc carry educational campaign increase awareness pulmonary hypertension health_care providers include information symptoms pulmonary hypertension importance early diagnosis current diagnostic criteria food_and_drug_administration therapies disease requires campaign target health_care providers including primary care physicians pediatricians nurse practitioners


Summary: Human Cloning Prohibition Act of 2009 - Amends the federal criminal code to prohibit any public or private person or entity, in or affecting interstate commerce, from: (1) performing or attempting to perform human cloning; (2) participating in an attempt to perform human cloning; or (3) shipping, receiving, or importing the product of human cloning for any purpose. Sets forth criminal and civil penalties for violations.Provides that nothing in this Act shall restrict areas of scientific research not specifically prohibited by this Act, including research in the use of nuclear transfer or other cloning techniques to produce molecules, DNA, cells other than human embryos, tissues, organs, plants, or animals other than humans.

human cloning prohibition act amends federal criminal code prohibit public private person entity affecting interstate commerce performing attempting perform human cloning participating attempt perform human cloning shipping receiving importing product human cloning purpose sets forth criminal civil penalties violations provides act shall restrict areas scientific research specifically prohibited act including research use nuclear transfer cloning techniques produce dna cells human tissues organs plants animals humans


Summary: Arthritis Prevention, Control, and Cure Act of 2010 - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services to develop and implement a National Arthritis Action Plan. Authorizes the Secretary, directly or through competitive grants, to conduct, support, and promote the coordination of research, investigations, demonstrations, training, and studies relating to the control, prevention, and surveillance of arthritis and other rheumatic diseases. Permits the Secretary, upon request of a grantee, to provide training, technical assistance, supplies, equipment, or services or detail any officer or employee of the Department of Health and Human Services (HHS) to aid the grantee in carrying out grant activities. Requires the Secretary to reduce the amount of payments under the grant by an amount equal to the costs of detailing personnel and the fair market value of any supplies, equipment, or services provided by the Secretary. Authorizes the Secretary to provide additional grant support to encourage the expansion of research related to the prevention and management of arthritis at the Centers for Disease Control and Prevention (CDC). Authorizes the Secretary to coordinate and carry out national education and outreach activities for arthritis and other rheumatic diseases, which may include public awareness campaigns, public service announcements, and community partnership workshops. Authorizes the Secretary to: (1) emphasize prevention, early diagnosis, and appropriate management of arthritis and opportunities for effective patient self-management; and (2) give priority to reaching high-risk or underserved populations. Authorizes the Secretary to award grants to a state or Indian tribe to provide support for comprehensive arthritis control and prevention programs and to enable such state or Indian tribe to provide public health surveillance, prevention, and control activities related to arthritis and other rheumatic diseases. Authorizes appropriations for FY2012-FY2016. (Sec. 3) Authorizes the Secretary to expand and intensify programs of the National Institutes of Health (NIH) with respect to research and related activities designed to improve the outcomes and quality of life for children with arthritis and other rheumatic diseases. (Sec. 4) Authorizes the Secretary to award institutional training grants to institutions to support pediatric rheumatology training to ensure an adequate future supply of pediatric rheumatologists.

prevention control cure act sec amends public_health_service_act authorize secretary health_and_human_services develop implement national action plan authorizes secretary directly competitive grants conduct support promote coordination research investigations demonstrations training studies relating control prevention surveillance diseases permits secretary request grantee provide training technical assistance supplies equipment services detail officer employee department_of_health_and_human_services hhs aid grantee carrying grant activities requires secretary reduce payments grant equal costs detailing personnel fair market value supplies equipment services provided secretary authorizes secretary provide additional grant support encourage expansion research related prevention management centers_for_disease_control_and_prevention cdc authorizes secretary coordinate carry national education outreach activities diseases include public awareness campaigns public service announcements community partnership workshops authorizes secretary emphasize prevention early diagnosis appropriate management opportunities effective patient self management priority reaching high risk underserved populations authorizes secretary award grants state indian tribe provide support comprehensive control prevention programs enable state indian tribe provide public health surveillance prevention control activities related diseases authorizes appropriations fy2012-fy2016 sec authorizes secretary expand intensify programs national_institutes_of_health nih respect research related activities designed improve outcomes quality life children diseases sec authorizes secretary award institutional training grants institutions support pediatric training ensure adequate future supply pediatric


Summary: Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010 - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to conduct research on acquired bone marrow failure diseases, which may address factors including: (1) trends in the characteristics of individuals who are diagnosed with such diseases, including age, race and ethnicity, general geographic location, sex, and family history; (2) the genetic and environmental factors, including exposure to toxins, that may be associated with developing such diseases; (3) approaches to treating such diseases; and (4) outcomes for individuals treated for such diseases, including outcomes for recipients of stem cell therapeutic products. Authorizes the Secretary to collaborate with the Radiation Injury Treatment Network of the C.W. Bill Young Cell Transplantation Program to: (1) augment data for studies; (2) access technical assistance that may be provided by the Network; or (3) perform joint research projects. (Sec. 3) Authorizes the Secretary to establish and coordinate outreach and informational programs targeted to minority populations, including Hispanic, Asian-American, Native Hawaiian, and Pacific Islander populations, that are affected by acquired bone marrow failure diseases. Includes among program activities: (1) making information about treatment options and clinical trials for such diseases publicly available; and (2) providing referral services for treatment options and clinical trials. (Sec. 4) Authorizes the Secretary, acting through the Director of the Agency for Healthcare Research and Quality, to award grants to researchers to study best practices with respect to diagnosing acquired bone marrow failure diseases and providing care to individuals with such diseases.

acquired bone marrow failure disease research treatment act sec amends public_health_service_act authorize secretary health_and_human_services hhs conduct research acquired bone marrow failure diseases address factors including trends characteristics individuals diagnosed diseases including age race ethnicity general geographic location sex family history genetic environmental factors including exposure toxins associated developing diseases approaches treating diseases outcomes individuals treated diseases including outcomes recipients stem cell therapeutic products authorizes secretary collaborate radiation injury treatment network bill young cell transplantation program augment data studies access technical assistance provided network perform joint research projects sec authorizes secretary establish coordinate outreach informational programs targeted minority populations including hispanic asian american native hawaiian pacific islander populations affected acquired bone marrow failure diseases includes program activities making information treatment options clinical trials diseases publicly available providing referral services treatment options clinical trials sec authorizes secretary acting director agency healthcare_research_and_quality award grants researchers study best practices respect diagnosing acquired bone marrow failure diseases providing care individuals diseases


Summary: Post-Abortion Depression Research and Care Act of 2009 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Institute of Mental Health (NIMH), to expand and intensify NIMH research and related activities with respect to post-abortion depression and psychosis. Requires the Director of NIMH to: (1) conduct or support research to expand the understanding of the causes of, and to find a cure for, such post-abortion conditions; and (2) conduct a study to determine the incidence and prevalence of cases of post-abortion conditions and the symptoms, severity, and duration of such cases, toward the goal of more fully identifying the characteristics of such cases and developing diagnostic techniques. Requires the Secretary to make grants to establish, operate, and coordinate effective and cost-efficient systems for the delivery of essential services to individuals with such post-abortion conditions.

post abortion depression research care act requires secretary health_and_human_services acting director national_institutes_of_health nih director national_institute_of_mental_health expand intensify research related activities respect post abortion depression requires director conduct support research expand understanding causes find cure post abortion conditions conduct study determine incidence prevalence cases post abortion conditions symptoms severity duration cases goal fully identifying characteristics cases developing diagnostic techniques requires secretary grants establish operate coordinate effective cost efficient systems delivery essential services individuals post abortion conditions


Summary: National Neurotechnology Initiative Act - Defines "neurotechnology" to mean the science and technology that allows an individual to analyze, understand, treat, and heal the brain and nervous system.Requires the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, under which the Secretary shall: (1) establish goals, priorities, and metrics for evaluation for federal neurotechnology research, development, and commercialization; (2) increase the investment in federal research, development, and translational programs in neurotechnology to achieve such goals; and (3) increase interagency coordination.Requires the Secretary to establish the National Neurotechnology Coordination Office and the National Neurotechnology Advisory Council.Requires the Director of the National Institutes of Health (NIH) to develop the Blueprint for Neuroscience Research to: (1) identify pervasive challenges in neuroscience and any technological barriers to solving such challenges; and (2) support the development of new tools, training opportunities, and other resources to assist neuroscientists in basic and clinical research. Directs the Commissioner of Food and Drugs to require the Directors of the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health to improve the timelines of the review process for neurology and psychiatry.Requires the Director of the National Neurotechnology Coordination Office to establish the American Neurotechnology Study Center.

national initiative act defines mean science_and_technology allows individual analyze understand treat heal brain nervous system requires secretary health_and_human_services implement national initiative secretary shall establish goals priorities metrics evaluation federal research development commercialization increase investment federal research development translational programs achieve goals increase interagency coordination requires secretary establish national coordination office national advisory_council requires director national_institutes_of_health nih develop neuroscience research identify pervasive challenges neuroscience technological barriers solving challenges support development new tools training opportunities resources assist basic clinical research directs commissioner food_and_drugs require directors center_for_drug_evaluation_and_research center_for_biologics_evaluation_and_research center_for_devices_and_radiological_health improve timelines review process psychiatry requires director national coordination office establish american study center


Summary: Cures Can Be Found Act of 2009 - Amends the Internal Revenue Code to allow tax credits for: (1) donations to stem cell research or storage facilities; and (2) donations of umbilical cord blood. Allows credits only for donations to facilities that do not engage in research on stem cells derived from human embryos. Allows a business tax credit for stem cell research and storage expenses.

cures found act amends_the_internal_revenue_code allow tax credits donations stem cell research storage facilities donations umbilical cord blood allows credits donations facilities engage research stem cells derived human allows business tax credit stem cell research storage expenses


Summary: Protection for Participants in Research Act of 2009 - Amends the Public Health Service Act to require all human subject research conducted, supported, or otherwise subject to federal regulation, to be conducted in accordance with the Common Rule and the vulnerable-population rules, as set forth in the Code of Federal Regulations. Requires the Secretary of Health and Human Services to review and harmonize such regulations. Requires informed consent before an individual may be a subject of human research. Requires an Institutional Review Board to approve all human subject research proposals. Directs the Secretary to establish criteria for determining whether a human subject research project must be conducted in accordance with a data safety and monitoring plan. Prohibits grants or awards to a public entity or private academic institution that does not have a program to educate investigators and Board members on the protection of human research subjects. Prohibits the use of federal funds for classified human subject research if: (1) the Board has waived the informed consent requirement; or (2) the research is exempt from Board review. Establishes the Office of Human Research Protections within the Office of the Secretary. Requires the Director of the Office to: (1) provide for the protection of human research subjects; (2) establish criteria regarding assurance of compliance with Common Rule requirements; and (3) coordinate federal activities with respect to the protection of human research subjects. Authorizes the Director to make grants for a model education program. Requires the Secretary to: (1) promulgate regulations enhancing the protection of people with diminished decision-making capacity participating in human subject research; and (2) study whether the number of certain members of Institutional Review Boards should be increased.

protection participants research_act amends public_health_service_act require human subject research conducted supported subject federal regulation conducted accordance common rule vulnerable population rules set forth code federal regulations requires secretary health_and_human_services review harmonize regulations requires informed consent individual subject human research requires institutional review board approve human subject research proposals directs secretary establish criteria determining human subject research project conducted accordance data safety monitoring plan prohibits grants awards public entity private academic institution program educate investigators board members protection human research subjects prohibits use federal funds classified human subject research board waived informed consent requirement research exempt board review establishes office human research protections office_of_the_secretary requires director office provide protection human research subjects establish criteria assurance compliance common rule requirements coordinate federal activities respect protection human research subjects authorizes director grants model education program requires secretary promulgate regulations enhancing protection people diminished decision making capacity participating human subject research study number certain members institutional review boards increased


Summary: Ovarian Cancer Biomarker Research Act of 2009 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate Ovarian Cancer Biomarker Centers of Excellence to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer, focusing on translational research of such biomarkers. Permits federal funds to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens; and (5) genetics, proteomics, and pathways of ovarian cancer as they relate to the discovery and development of biomarkers. Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); and (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist in designing and implementing national clinical trials to determine the utility of using such biomarkers. Requires a national data center to be established in, and supported by, the Institute to conduct statistical analyses of trial data and to store such analyses and data, which shall be used to establish clinical guidelines to provide the medical community with information regarding the use of validated biomarkers.

cancer research_act amends public_health_service_act require director national_cancer_institute enter cooperative agreements grants public nonprofit entities establish operate cancer centers_of_excellence conduct research biomarkers use risk early detection screening cancer focusing translational research biomarkers permits federal funds research development characterization new biomarkers refinement existing biomarkers clinical laboratory validation biomarkers development implementation clinical epidemiological research utilization biomarkers development implementation repositories new tissue biological specimens pathways cancer relate discovery development biomarkers requires director available research tissue specimens clinical research cancer funded department_of_health_and_human_services hhs establish cancer clinical trial committee assist designing implementing national clinical trials determine utility biomarkers requires national data center established supported institute conduct statistical analyses trial data store analyses data shall establish clinical guidelines provide medical community information use validated biomarkers


Summary: Childhood Cancer Survivorship Research and Quality of Life Act of 2009 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand and intensify the CDC's cancer control programs, including programs for conducting surveillance activities or supporting state comprehensive cancer control programs. Requires the Director of the National Cancer Institute to coordinate the activities of the National Institutes of Health (NIH) with respect to cancer survivorship, including child cancer survivorship. Requires the Director of NIH, acting through the Director of the Institute, to make grants for research relating to: (1) childhood cancer survivors within minority populations; and (2) health disparities in cancer survivorship outcomes within minority or other medically underserved populations. Requires the Director of NIH to conduct or support research to evaluate systems of follow-up care for childhood cancer survivors. Directs the Secretary to make grants to establish or improve training programs for health care professionals to: (1) improve the quality of immediate and long-term follow-up care for survivors of childhood cancers and their families; and (2) ensure that such care is linguistically and culturally competent. Requires the Director of NIH to make grants to establish pilot programs to develop, study, or evaluate model systems for monitoring and caring for childhood cancer survivors. Requires the Secretary to make grants to: (1) establish and operate a clinic for comprehensive long-term follow-up services for childhood cancer survivors; and (2) improve physical and psychosocial care for childhood cancer survivors.

childhood cancer survivorship research quality life act amends public_health_service_act direct secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc expand intensify cdc cancer control programs including programs conducting surveillance activities supporting state comprehensive cancer control programs requires director national_cancer_institute coordinate activities national_institutes_of_health nih respect cancer survivorship including child cancer survivorship requires director nih acting director institute grants research relating childhood cancer survivors minority populations health disparities cancer survivorship outcomes minority medically underserved populations requires director nih conduct support research evaluate systems follow care childhood cancer survivors directs secretary grants establish improve training programs health_care professionals improve quality immediate long term follow care survivors childhood cancers families ensure care linguistically culturally competent requires director nih grants establish pilot programs develop study evaluate model systems monitoring caring childhood cancer survivors requires secretary grants establish operate clinic comprehensive long term follow services childhood cancer survivors improve physical psychosocial care childhood cancer survivors


Summary: Inflammatory Bowel Disease Research and Awareness Act - Amends the Public Health Service Act to require the Centers for Disease Control and Prevention (CDC) to: (1) conduct, support, and expand epidemiology research on inflammatory bowel disease (IBD) (i.e., Crohn's disease and ulcerative colitis) in pediatric and adult populations and establish a registry of pediatric IBD patients; (2) enter into cooperative agreements to develop and administer such epidemiology research and the pediatric IBD registry; and (3) award grants to increase awareness of IBD among the general public and health care providers. Requires the Director of the National Institutes of Health (NIH) to include information on IBD research in the biennial reports of NIH to Congress. Expresses the sense of Congress that the Directors of NIH and the National Institute of Diabetes and Digestive and Kidney Diseases should support specified research and training goals for inflammatory bowel disease.

disease research awareness act_-_amends public_health_service_act require centers_for_disease_control_and_prevention cdc conduct support expand epidemiology research disease disease pediatric adult populations establish registry pediatric patients enter cooperative agreements develop administer epidemiology research pediatric registry award grants increase awareness general public health_care providers requires director national_institutes_of_health nih include information research biennial reports nih congress expresses sense congress directors nih national institute diabetes kidney diseases support specified research training goals disease


Summary: Scleroderma Research and Awareness Act of 2010 - Amends the Public Health Service Act to authorize the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate NIH activities with respect to scleroderma, with particular emphasis on: (1) research focused on the etiology of scleroderma and the development of new treatment options; (2) clinical research to evaluate new treatments options; and (3) basic research on the relationship between scleroderma and secondary conditions, such as pulmonary hypertension, gastroparesis, Raynaud's phenomenon, Sjogren's Syndrome. Authorizes the Secretary of Health and Human Services (HHS) to carry out an educational campaign to increase public awareness of scleroderma. Permits print, video, and web-based materials distributed through this campaign to include: (1) basic information on scleroderma and its symptoms; and (2) information on the incidence and prevalence of scleroderma, diseases and conditions affiliated with scleroderma, or the importance of early diagnosis and treatment of scleroderma.

research awareness act amends public_health_service_act authorize director national_institutes_of_health nih expand intensify coordinate nih activities respect particular emphasis research focused development new treatment options clinical research evaluate new treatments options basic research relationship secondary conditions pulmonary hypertension syndrome authorizes secretary health_and_human_services hhs carry educational campaign increase public awareness permits print video web based materials distributed campaign include basic information symptoms information incidence prevalence diseases conditions affiliated importance early diagnosis treatment


Summary: Taxpayers' Cancer Research Funding Act of 2009- Amends the Internal Revenue Code to allow taxpayers to designate on their tax returns a $5 contribution to the Breast and Prostate Cancer Research Fund ($10 for joint returns). Establishes in the Treasury the Breast and Prostate Cancer Research Fund to award grants for breast or prostate cancer research.

taxpayers cancer research funding act amends_the_internal_revenue_code allow taxpayers designate tax returns contribution breast prostate cancer research fund joint returns establishes treasury breast prostate cancer research fund award grants breast prostate cancer research


Summary: Comparative Effectiveness Research Act of 2009 - Amends title XI (General Provisions, Peer Review, and Administrative Simplification) of the Social Security Act to provide for a program of comparative effectiveness research for health care. Defines "comparative effectiveness research" as research evaluating and comparing the implications and outcomes of two or more health care strategies to address a particular medical condition. Establishes the Health Care Comparative Effectiveness Research Institute as a nonprofit, nongovernmental corporation to conduct research on the effectiveness of health care treatments, including pharmaceuticals, medical devices and procedures, and other therapies. Requires the Institute to: (1) identify national priorities for comparative clinical effectiveness research; (2) establish and update a research project agenda and provide for peer review of research; (3) establish a standing methodology committee for developing the science of comparative effectiveness research; and (4) disseminate research findings. Amends the Internal Revenue Code to establish in the Treasury the Comparative Effectiveness Research Trust Fund. Provides revenues for the Trust Fund by: (1) transferring amounts from certain appropriations for comparative effectiveness research, from the General Fund, and from the Medicare Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds; and (2) imposing a fee on certain accident or health insurance policies and self-insured health plans. Requires the Comptroller General to review financial audits of the Institute and assess the adequacy and use of funding. Terminates all funding for the Trust Fund after FY2020.

comparative effectiveness research_act amends title general_provisions peer_review administrative simplification social_security_act provide program comparative effectiveness research health_care defines comparative effectiveness research research evaluating comparing implications outcomes health_care strategies address particular medical condition establishes health_care comparative effectiveness research institute nonprofit nongovernmental corporation conduct research effectiveness health_care treatments including pharmaceuticals medical devices procedures therapies requires institute identify national priorities comparative clinical effectiveness research establish update research project agenda provide peer_review research establish standing methodology committee developing science comparative effectiveness research disseminate research findings amends_the_internal_revenue_code establish treasury comparative effectiveness research trust_fund provides revenues trust_fund transferring amounts certain appropriations comparative effectiveness research general_fund medicare federal hospital insurance federal supplementary_medical_insurance trust funds imposing fee certain accident health insurance policies self insured health plans requires comptroller_general review financial audits institute assess adequacy use funding terminates funding trust_fund fy2020


Summary: Prostate Cancer Research and Prevention Act - Amends the Public Health Service Act to authorize appropriations through FY2015 for: (1) the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to states and local health departments to carry out preventive health measures related to prostate cancer; and (2) the Director of the National Cancer Institute to expand, intensify, and coordinate prostate cancer research activities.

prostate cancer research prevention act_-_amends public_health_service_act authorize appropriations fy2015 secretary health_and_human_services hhs acting director centers_for_disease_control_and_prevention cdc grants states local health departments carry preventive health measures related prostate cancer director national_cancer_institute expand intensify coordinate prostate cancer research activities


Summary: Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2009 or the PATIENTS Act of 2009 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from the conduct of comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009, to deny coverage of an item or service under a federal health care program. Requires the Secretary to ensure that comparative effectiveness research conducted or supported by the federal government accounts for factors contributing to differences in the treatment response and preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.

preserving access targeted individualized effective new treatments services patients act patients act prohibits secretary health_and_human_services hhs data obtained conduct comparative effectiveness research including research conducted supported funds appropriated american_recovery_and_reinvestment_act deny coverage item service federal health_care program requires secretary ensure comparative effectiveness research conducted supported federal_government accounts factors contributing differences treatment response preferences patients including patient reported outcomes personalized medicine unique needs health disparity populations indirect patient benefits


Summary: Accelerate Cures for Patients Act of 2009 - Amends the Public Health Service Act to authorize additional appropriations to the National Institutes of Health (NIH) to conduct or support medical research that relates to cancer, cardiovascular disease, diabetes, Alzheimer's disease, Parkinson's disease, or other diseases or conditions and that has the greatest potential for near-term clinical benefit in human patients, as indicated by substantial evidence from basic research or by substantial clinical evidence. Allows such evidence to include: (1) evidence of improvement in one or more human patients suffering from illness or injury, as documented in reports by professional medical or scientific associations or in peer-reviewed medical or scientific literature; and (2) approval for use in human trials by the Food and Drug Administration (FDA).

accelerate cures patients act amends public_health_service_act authorize additional appropriations national_institutes_of_health nih conduct support medical research relates cancer cardiovascular disease diabetes alzheimer disease parkinson disease diseases conditions greatest potential near term clinical benefit human patients indicated substantial evidence basic research substantial clinical evidence allows evidence include evidence improvement human patients suffering illness injury documented reports professional medical scientific associations peer reviewed medical scientific literature approval use human trials food_and_drug_administration fda


Summary: National Quality Cancer Care Demonstration Project Act of 2009 - Directs the Secretary of Health and Human Services to establish a quality cancer care demonstration project for the purpose of establishing quality metrics and aligning payment incentives under title XVIII (Medicare) of the Social Security Act in the areas of treating planning and follow-up cancer care for Medicare beneficiaries with cancer.

national quality cancer care demonstration project act directs secretary health_and_human_services establish quality cancer care demonstration project purpose establishing quality metrics aligning payment incentives title xviii medicare social_security_act areas treating planning follow cancer care medicare beneficiaries cancer


Summary: Environmental Hormone Disruption Research Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to establish a comprehensive program to: (1) research the health effects on women and children that may result through disruption of the hormone systems; (2) carry out research, development, and demonstrations on technologies to mitigate the occurrence of hormone-disrupting pollutants in the environment and their unintended effects on ecological and wildlife health, in cooperation with the United States Geological Survey (USGS); and (3) coordinate U.S. research on hormone disruption with research conducted in other nations. Requires the program to provide for: (1) the collection and dissemination of scientifically valid information on human health effects of hormone-disrupting pollutants, the extent of human exposure to such pollutants, and the exposure of wildlife species to such pollutants and possible associated health effects; and (2) research on mechanisms by which such pollutants interact with biological systems, testing for hormone disruption, and the identity and fate of hormone-disrupting pollutants in the environment. Directs the House Committee on Energy and Commerce to hold a hearing on program implementation. Gives the Director principal responsibility for conducting and coordinating research on the unintended effects of hormone-disrupting pollutants on human health and the environment. Requires the Secretary of Health and Human Services (HHS) to establish the Hormone Disruption Research Interagency Commission. Establishes a Hormone Disruption Research Panel to make recommendations on the design and implementation of the program.

environmental disruption research_act amends public_health_service_act require director national_institute_of_environmental_health_sciences establish comprehensive program research health effects women children result disruption systems carry research development demonstrations technologies mitigate occurrence disrupting pollutants environment unintended effects ecological wildlife health cooperation united_states_geological_survey usgs coordinate research disruption research conducted nations requires program provide collection dissemination scientifically valid information human health effects disrupting pollutants extent human exposure pollutants exposure wildlife species pollutants possible associated health effects research mechanisms pollutants interact biological systems testing disruption identity disrupting pollutants environment directs house_committee_on_energy_and_commerce hold hearing program implementation gives director principal responsibility conducting coordinating research unintended effects disrupting pollutants human health environment requires secretary health_and_human_services hhs establish disruption research interagency commission establishes disruption research panel recommendations design implementation program


Summary: Women's Environmental Health and Disease Prevention Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of centers to conduct multidisciplinary research on environmental factors that may be related to the development of women's health conditions. Requires each such center to: (1) conduct basic or clinical research; (2) develop protocols and conduct training programs for physicians, scientists, nurses, and other health and allied health professionals; (3) disseminate information to such professionals and the public; and (4) emphasize activities that are directed toward preventing the development in women of the diseases and conditions involved. Allows a center to use funds to provide stipends for health and allied health professionals enrolled in training programs. Requires each center to establish and maintain ongoing collaborations with community organizations in the geographic area served by the center, including organizations that represent women or children with disorders that appear to stem from environmental factors. Requires the Director to provide for the coordination of information among centers and ensure regular communication between them. Directs the House Committee on Energy and Commerce to hold a hearing on the Director's implementation of this Act.

women environmental health disease prevention act amends public_health_service_act require director national_institute_of_environmental_health_sciences grants development operation centers conduct multidisciplinary research environmental factors related development women health conditions requires center conduct basic clinical research develop protocols conduct training programs physicians scientists nurses health allied health professionals disseminate information professionals public emphasize activities directed preventing development women diseases conditions involved allows center use funds provide stipends health allied health professionals enrolled training programs requires center establish maintain ongoing collaborations community organizations geographic area served center including organizations represent women children disorders appear stem environmental factors requires director provide coordination information centers ensure regular communication directs house_committee_on_energy_and_commerce hold hearing director implementation act


Summary: Endocrine Disruption Prevention Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to establish the Endocrine Disruption Prevention Program, under which the Director shall: (1) conduct and support multidisciplinary research to improve the understanding of endocrine disruption; and (2) conduct workshops and fora on health effects associated with environmental agents that may affect the endocrine system. Requires the Director to establish an Endocrine Disruption Program Panel, which shall: (1) provide advice to the Director on the conduct and support of research; (2) evaluate existing population-level biomonitoring and biobanking surveillance and research programs and recommend changes needed to develop data on human exposures and effects to support the Program; and (3) develop a list of chemicals of concern for endocrine disruption effects and make findings with respect to such chemicals. Authorizes individuals to petition the Panel to determine whether a chemical should be listed or to revise a finding or determination based on new information. Requires the Director, if the Panel finds that data are sufficient to determine that there is at least a minimal level of concern associated with a chemical's potential to disrupt the human endocrine system, to transmit the finding, including the routes and sources of exposure to the chemical, to each federal agency with authority to regulate the chemical. Requires each federal agency that receives such a transmission: (1) to reply to the Director describing the agency's regulatory authority, past actions in connection with the chemical, and proposed action to protect human health from the potential endocrine disruption effects of exposure to the chemical; and (2) within one year, to report on the actions taken and future actions proposed by the Agency in response to the Panel's finding. Requires the Director to establish a program to support graduate and postdoctoral training in fields related to the prevention of endocrine disruption.

endocrine disruption prevention act amends public_health_service_act require director national_institute_of_environmental_health_sciences establish endocrine disruption prevention program director shall conduct support multidisciplinary research improve understanding endocrine disruption conduct workshops fora health effects associated environmental agents affect endocrine system requires director establish endocrine disruption program panel shall provide advice director conduct support research evaluate existing population level surveillance research programs recommend changes needed develop data human exposures effects support program develop list chemicals concern endocrine disruption effects findings respect chemicals authorizes individuals petition panel determine chemical listed revise finding determination based new information requires director panel finds data sufficient determine minimal level concern associated chemical potential disrupt human endocrine system transmit finding including routes sources exposure chemical federal agency authority regulate chemical requires federal agency receives transmission reply director describing agency regulatory authority past actions connection chemical proposed action protect human health potential endocrine disruption effects exposure chemical year report actions taken future actions proposed agency response panel finding requires director establish program support graduate postdoctoral training fields related prevention endocrine disruption


Summary: Prostate Research, Imaging, and Men's Education Act of 2010 or the PRIME Act of 2010 - Requires the Secretary of Health and Human Services (HHS), acting through the Director of the National Institutes of Health (NIH), to: (1) carry out a program to expand and intensify research to develop advanced imaging technologies for prostate cancer detection, diagnosis, and treatment comparable to mammogram technology; and (2) utilize the National Institute of Biomedical Imaging and Bioengineering and the National Cancer Institute for advanced stages of research in prostate imaging. Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration, to: (1) carry out a grant program to encourage the early stages of research in prostate imaging to develop and implement new ideas, proof of concepts, and pilot studies for high-risk technologic innovation; and (2) establish interdisciplinary private-public partnerships to develop research strategies for expedited innovation in imaging and image-guided treatment. Directs the Secretary: (1) to carry out a national campaign to increase awareness and knowledge with respect to the need for prostate cancer screening and for improved detection technologies; (2) in carrying out the program and the campaign, to recognize and address the racial disparities in the incidences of prostate cancer and mortality rates and any racial barriers in access to care and participation in clinical trials; (3) establish a program to award grants to nonprofit private entities to test alternative outreach and education strategies; and (4) carry out research to develop an improved prostate cancer screening blood test using in-vitro detection.

prostate_research imaging men education act prime act requires secretary health_and_human_services hhs acting director national_institutes_of_health nih carry program expand intensify research develop advanced imaging technologies prostate cancer detection diagnosis treatment comparable mammogram technology utilize national institute biomedical imaging national_cancer_institute advanced stages research prostate imaging requires secretary acting administrator health_resources_and_services_administration carry grant program encourage early stages research prostate imaging develop implement new ideas proof concepts pilot studies high risk innovation establish interdisciplinary private public partnerships develop research strategies expedited innovation imaging image guided treatment directs secretary carry national campaign increase awareness knowledge respect need prostate cancer screening improved detection technologies carrying program campaign recognize address racial disparities incidences prostate cancer mortality rates racial barriers access care participation clinical trials establish program award grants nonprofit private entities test alternative outreach education strategies carry research develop improved prostate cancer screening blood test vitro detection


Summary: Create Jobs by Expanding the R&D Tax Credit Act of 2010 - Amends the Internal Revenue Code to: (1) increase the rate of the tax credit for increasing research activities in 2010 and 2011; (2) extend such tax credit through 2011; and (3) allow certain small business concerns to assign research tax credit amounts in 2010 and 2011.

create jobs expanding tax credit act amends_the_internal_revenue_code increase rate tax credit increasing research activities extend tax credit allow certain small business concerns assign research tax credit amounts


Summary: Stem Cell Research Advancement Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to conduct and support research that utilizes human stem cells, including human embryonic stem cells. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of reproductive treatment, and were in excess of the needs of the individuals seeking such treatment; (2) it was determined through consultation with the individuals seeking reproductive treatment that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking reproductive treatment donated the embryos with written informed consent and received no financial or other inducements. Requires the Secretary to maintain, review every three years, and update as scientifically warranted, guidelines applicable to the conduct or support of human stem cell research by HHS. Prohibits the Secretary from using any funds for the conduct or support of human cloning. Requires the Director of the National Institutes of Health (NIH) to include in its biennial report to Congress a summary of research activities on human stem cells.

stem cell research advancement act amends public_health_service_act require secretary health_and_human_services hhs conduct support research utilizes human stem cells including human stem cells limits research stem cells meet following requirements stem cells derived human donated vitro fertilization clinics created purposes reproductive treatment excess needs individuals seeking treatment determined consultation individuals seeking reproductive treatment implanted woman individuals seeking reproductive treatment donated written informed consent received financial inducements requires secretary maintain review years update scientifically warranted guidelines applicable conduct support human stem cell research hhs prohibits secretary funds conduct support human cloning requires director national_institutes_of_health nih include biennial report congress summary research activities human stem cells


Summary: Tinnitus Research for Military Health Improvement Act - Directs the Secretary of Defense (DOD) to establish one or more centers of excellence for the study of tinnitus. Requires such centers to be established at military installations where members of the Armed Forces perform activities involving high rates of sound, including artillery instruction. Outlines center activities, including researching and enhancing treatments for members with tinnitus. Requires the inclusion, within a current medical tracking system for members deployed overseas, of an aural screening which shall include an assessment of tinnitus. Directs the Secretary to establish a grant program to assist eligible institutions in conducting research on recurrent, chronic, or severe tinnitus and peripheral neurological conditions. Makes eligible for such grants: (1) a hospital with an approved teaching program as defined under the Social Security Act; or (2) an educational institution with demonstrated expertise in tinnitus research. Requires the Secretary to designate a senior DOD official to act as the executive agent for tinnitus.

tinnitus research military health improvement act_-_directs secretary defense dod establish centers_of_excellence study tinnitus requires centers established military installations members armed_forces perform activities involving high rates sound including artillery instruction outlines center activities including researching enhancing treatments members tinnitus requires inclusion current medical tracking system members deployed overseas screening shall include assessment tinnitus directs secretary establish grant program assist eligible institutions conducting research recurrent chronic severe tinnitus peripheral neurological conditions makes eligible grants hospital approved teaching program defined social_security_act educational institution demonstrated expertise tinnitus research requires secretary designate senior dod official act executive agent tinnitus


Summary: Medical Checklist Act of 2010 - Requires the Director of the Agency for Healthcare Research and Quality, acting through the Center for Quality Improvement and Patient Safety, to conduct research and a study regarding the development and efficacy of medical checklists, including regarding: (1) the testing of different models of medical checklists; (2) an examination of checklist development and use in other industries; and (3) a measurement of the effects of the use of medical checklists on patient safety and health outcomes. Requires dissemination of the results of such study to patient safety organizations. Defines "medical checklist" as a predetermined, evidence-based, well-defined set of steps that should be completed during a designated medical clinical encounter or medical procedure. Requires the HIT Policy Committee to develop policy recommendations regarding: (1) the extent to which the use of medical checklists should be incorporated into health information technology systems; and (2) measures to determine the effectiveness of such use. Requires the Secretary to enter into an agreement with the Institute of Medicine and the National Academy of Engineering of the National Academies to conduct a study on medical checklists that includes: (1) a review of available medical checklists and similar quality improvement techniques; (2) an identification of areas of research needed to improve medical checklists; (3) an analysis of organizational impediments to the adoption and use of medical checklists; and (4) a determination of whether the availability of an increased number of medical checklists would improve patient safety and health outcomes.

medical checklist act requires director agency healthcare_research_and_quality acting center quality improvement patient safety conduct research study development efficacy medical checklists including testing different models medical checklists examination checklist development use industries measurement effects use medical checklists patient safety health outcomes requires dissemination results study patient safety organizations defines medical checklist predetermined evidence based defined set steps completed designated medical clinical encounter medical procedure requires hit policy committee develop policy recommendations extent use medical checklists incorporated health information technology systems measures determine effectiveness use requires secretary enter agreement institute_of_medicine national_academy_of_engineering national academies conduct study medical checklists includes review available medical checklists similar quality improvement techniques identification areas research needed improve medical checklists analysis organizational impediments adoption use medical checklists determination availability increased number medical checklists improve patient safety health outcomes


Summary: Authorizes the Secretary of Veterans Affairs (VA) to enter into agreements with a university, hospital, or other similar entity for the treatment of, and research on, post-traumatic stress disorder.

authorizes secretary veterans_affairs enter agreements university hospital similar entity treatment research post traumatic stress disorder


Summary: Stem Cell Therapeutic and Research Reauthorization Act of 2010 - (Sec. 2) Amends the Stem Cell Therapeutic and Research Act of 2005 to revise provisions related to the National Cord Blood Inventory (the Inventory), including to establish an inventory goal of at least 150,000 new units of cord blood to be made available under the C.W. Bill Young Cell Transplantation Program (the Program). (Currently, the number of units of cord blood is capped at 150,000.) Revises application requirements for cord blood banks participating in the Inventory to require such banks to: (1) make assurances that cord blood units will be available for direct transplantation until it is released for transplantation for a first degree relative; (2) participate in the Program for a period of at least ten years, beginning on the last date on which the recipient receives federal funds under a contract; (3) provide a plan to increase cord blood unit collections at collection sites that exist at the time of application, assist with the establishment of new collection sites, or contract with new collection sites; and (4) annually provide to the Secretary of Health and Human Services (HHS) a plan for, and demonstrate, ongoing measurable progress toward achieving self-sufficiency of cord blood unit collection and banking operations. Revises the requirements for a contract extension to make a qualified cord blood bank eligible for a five-year extension if the bank demonstrates a superior ability to satisfy the requirements of the contract and achieve the overall goals for which the contract was awarded. Redefines the term "first-degree relative" to exclude a parent. Authorizes appropriations for FY2011-FY2015 for the Inventory. Amends the Public Health Service Act to require the Program to support and expand studies and demonstration and outreach projects that focus on: (1) remote collection of cord blood units; and (2) novel approaches or incentives to encourage innovative technological advances that could be used to collect cord blood units. Defines "remote collection" to mean the collection of cord blood units at locations that do not have written contracts with cord blood banks for collection support. Requires the Secretary to: (1) set an annual goal of increasing collections of high quality cord blood units; (2) identify at least one demonstration or outreach project to replicate and expand nationwide, as appropriate; and (3) submit a plan for meeting such goal to the relevant congressional committees if no such project can be identified. Revises privacy requirements to protect the identity and privacy of patients and donors in accordance with federal and state law. Requires the Secretary to submit an interim report to Congress within 180 days of enactment of this Act describing: (1) the methods to distribute federal funds to cord blood banks; (2) how cord blood banks contract with collection sites for the collection of cord blood units; and (3) recommendations for improving the methods to distribute federal funds to encourage the efficient collection of high-quality and diverse cord blood units. Directs the Advisory Council on Blood Stem Cell Transplantation to submit recommendations to the Secretary with respect to remote collection of cord blood units. Authorizes appropriations for FY2011-FY2015 to carry out the Program. Directs the Comptroller General to submit to the relevant congressional committees and the Secretary a report reviewing studies, demonstration programs, and outreach efforts for the purpose of increasing cord blood unit donation and collection for the Inventory to ensure a high-quality and genetically diverse inventory of cord blood units.

stem cell therapeutic research reauthorization act sec amends stem cell therapeutic research_act revise provisions related national cord blood inventory inventory including establish inventory goal new units cord blood available bill young cell transplantation program program currently number units cord blood capped revises application requirements cord blood banks participating inventory require banks assurances cord blood units available direct transplantation released transplantation degree relative participate program period years beginning date recipient receives federal funds contract provide plan increase cord blood unit collections collection sites exist time application assist establishment new collection sites contract new collection sites annually provide secretary health_and_human_services hhs plan demonstrate ongoing measurable progress achieving self sufficiency cord blood unit collection banking operations revises requirements contract extension qualified cord blood bank eligible year extension bank demonstrates superior ability satisfy requirements contract achieve overall goals contract awarded redefines term degree relative exclude parent authorizes appropriations fy2011 fy2015 inventory amends public_health_service_act require program support expand studies demonstration outreach projects focus remote collection cord blood units novel approaches incentives encourage innovative technological advances collect cord blood units defines remote collection mean collection cord blood units locations written contracts cord blood banks collection support requires secretary set annual goal increasing collections high quality cord blood units identify demonstration outreach project replicate expand nationwide appropriate submit plan meeting goal relevant congressional committees project identified revises privacy requirements protect identity privacy patients donors accordance federal state law requires secretary submit interim report congress days enactment act describing methods distribute federal funds cord blood banks cord blood banks contract collection sites collection cord blood units recommendations improving methods distribute federal funds encourage efficient collection high quality diverse cord blood units directs advisory_council blood stem cell transplantation submit recommendations secretary respect remote collection cord blood units authorizes appropriations fy2011 fy2015 carry program directs comptroller_general submit relevant congressional committees secretary report reviewing studies demonstration programs outreach efforts purpose increasing cord blood unit donation collection inventory ensure high quality genetically diverse inventory cord blood units


Summary: Stem Cell Therapeutic and Research Reauthorization Act of 2010 - Amends the Stem Cell Therapeutic and Research Act of 2005 to revise the National Cord Blood Inventory Program, including to: (1) remove the cap of 150,000 new units of cord blood to be made available for transplantation under the Program; and (2) require an application under the Program to include a  plan for, and demonstration of, ongoing measurable progress toward achieving self-sufficiency of cord blood unit collection and banking operations. Extends financial support provided under the Program for an additional five years. (Current law allows financial support for a maximum of ten years.) Sets forth requirements for such an extension, including that a qualified cord blood bank demonstrate a superior ability to satisfy the requirements of such Program and achieve the overall goals for which the contract was awarded. Redefines the term "first-degree relative" to exclude a parent. Reauthorizes appropriations for FY2011-FY2015 for the collection or maintenance of cord blood. Amends the Public Health Service Act to revise the requirements of the C.W. Bill Young Cell Transplantation Program to: (1) require studies and projects under such Program to include exploring novel approaches or incentives to expand the number of cord blood unit collection sites partnering with federally-supported cord blood banks; and (2) revise privacy provisions to protect the privacy of patients and donors in accordance with federal and state law. Reauthorizes appropriations for such Program for FY2011-FY2015. Directs the Comptroller General to submit a report to the relevant congressional committees and the Secretary of Health and Human Services (HHS) that reviews studies, demonstration programs, and outreach efforts to increase  cord blood unit donation and collection.

stem cell therapeutic research reauthorization act amends stem cell therapeutic research_act revise national cord blood inventory program including remove cap new units cord blood available transplantation program require application program include plan demonstration ongoing measurable progress achieving self sufficiency cord blood unit collection banking operations extends financial support provided program additional years current law allows financial support maximum years sets forth requirements extension including qualified cord blood bank demonstrate superior ability satisfy requirements program achieve overall goals contract awarded redefines term degree relative exclude parent reauthorizes appropriations fy2011 fy2015 collection maintenance cord blood amends public_health_service_act revise requirements bill young cell transplantation program require studies projects program include exploring novel approaches incentives expand number cord blood unit collection sites partnering federally supported cord blood banks revise privacy provisions protect privacy patients donors accordance federal state law reauthorizes appropriations program fy2011 fy2015 directs comptroller_general submit report relevant congressional committees secretary health_and_human_services hhs reviews studies demonstration programs outreach efforts increase cord blood unit donation collection


Summary: Life Sciences Jobs and Investment Act of 2010 - Amends the Internal Revenue Code to allow: (1) an increased research tax credit for qualified initial life sciences research expenses; and (2) certain corporations a tax deduction for investments in the United States to hire scientists and researchers engaged in life science research and to fund life science research at universities, qualified research incubators, and other qualified organizations. Terminates such tax incentives after 2015. Defines "qualified initial life sciences research expenses" as amounts, up to $150 million, attributable to the study of biology, biochemistry, biophysics, bioengineering, microbiology, genetics, or physiology, but excluding sociology or psychology.

life sciences jobs investment act amends_the_internal_revenue_code allow increased research tax credit qualified initial life sciences research expenses certain corporations tax deduction investments united_states hire scientists researchers engaged life science research fund life science research universities qualified research incubators qualified organizations terminates tax incentives defines qualified initial life sciences research expenses amounts million attributable study biology excluding psychology


Summary: Making Investments Now for Dementia Act of 2010 - Authorizes the Secretary of the Treasury (the Secretary) to issue bonds to aid in the funding of Alzheimer's research in consultation with the Secretary of Health and Human Services (HHS) and the Director of the National Institutes of Health (NIH). Declares that the bonds authorized under this Act shall be in such form and denominations, and shall be subject to such terms and conditions of issue, conversion, redemption, maturation, payment, and rate of interest, as the Secretary may prescribe. Requires the Secretary to submit an annual report to Congress describing the actions taken by the Secretaries during the year, with the first such report describing the implementation of the program and subsquent reports describing the use of funds and the status of the program. Authorizes appropriations to the Director of NIH for research on Alzheimer's research equal to the amounts received by the Secretary from the sale of bonds under this Act, less amounts determined by the Secretary to be necessary for administration of such sales. Expresses the sense of Congress that any funds collected pursuant to this Act are in addition to yearly appropriated funds and are not to be used to supplement current funding.

making investments dementia act authorizes secretary treasury secretary issue bonds aid funding alzheimer research consultation secretary health_and_human_services hhs director national_institutes_of_health nih declares bonds authorized act shall form shall subject terms conditions issue conversion redemption payment rate interest secretary prescribe requires secretary submit annual report congress describing actions taken secretaries year report describing implementation program reports describing use funds status program authorizes appropriations director nih research alzheimer research equal amounts received secretary sale bonds act amounts determined secretary necessary administration sales expresses sense congress funds collected pursuant act addition yearly appropriated funds supplement current funding


Summary: Regenerative Medicine Promotion Act of 2010 - Requires the Secretary of Health and Human Services (HHS) to: (1) submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine; and (2) establish a Regenerative Medicine Coordinating Council in the Office of the Secretary. Includes among the duties of the Council: (1) preparing a national strategy for the promotion of research into regenerative medicine and the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; (2) identifying sources of funding for research into regenerative medicine and areas where such funding is inadequate; and (3) making recommendations regarding federal policies to support development and marketing of regenerative medicine products. Authorizes the Secretary, acting through the Director of the National Institutes of Health (NIH), to make grants for: (1) basic or preclinical research into regenerative medicine; (2) research and development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; and (3) the making of an investigational new drug application or an investigational device exemption application within four years of receiving such grant. Amends the Public Health Service Act to authorize the Director of NIH to award grants, contracts, or cooperative agreements to accelerate the development of high need cures through the development of medical products and behavioral therapies for use in regenerative medicine. Authorizes the Secretary, acting through the Commissioner of Food and Drugs, to: (1) conduct, support, or collaborate in regulatory research to assist the Food and Drug Administration (FDA) in performing its functions with respect to regenerative medicine; or (2) make grants to fund regulatory research for such purpose.

medicine promotion act requires secretary health_and_human_services hhs submit congress report identifying ongoing federal programs activities medicine establish medicine coordinating council office_of_the_secretary includes duties council preparing national strategy promotion research medicine development drugs biological products medical devices use medicine identifying sources funding research medicine areas funding inadequate making recommendations federal policies support development marketing medicine products authorizes secretary acting director national_institutes_of_health nih grants basic preclinical research medicine research development drugs biological products medical devices use medicine making investigational new drug application investigational device exemption application years receiving grant amends public_health_service_act authorize director nih award grants contracts cooperative agreements accelerate development high need cures development medical products behavioral therapies use medicine authorizes secretary acting commissioner food_and_drugs conduct support collaborate regulatory research assist food_and_drug_administration fda performing functions respect medicine grants fund regulatory research purpose


Summary: Establishes in the Uniformed Services University of the Health Sciences the United States Military Cancer Institute, headed by a Director, to carry out research studies on: (1) the epidemiological features of cancer among populations of various ethnic origins, as well as complementary research on oncologic nursing; (2) the prevention and early detection of cancer; and (3) basic, translational, and clinical investigation matters relating to such studies. Directs the Institute to conduct the study in collaboration with other cancer research organizations and entities selected by the Institute.

establishes uniformed_services university health sciences united_states military cancer institute headed director carry research studies epidemiological features cancer populations ethnic complementary research nursing prevention early detection cancer basic translational clinical investigation matters relating studies directs institute conduct study collaboration cancer research organizations entities selected institute


Summary: Ethical Stem Cell Research Tax Credit Act of 2009 - Amends the Internal Revenue Code to allow a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines "qualified stem cell research expenses" as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: (1) the creation of a human embryo for research purposes; (2) the destruction of or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell for prohibited purposes.

ethical stem cell research tax credit act amends_the_internal_revenue_code allow tax credit qualified stem cell research expenses paid incurred taxable year defines qualified stem cell research expenses expenses carrying basic applied research develop techniques isolation production testing human clinical use stem cells result improved understanding treatments diseases adverse health conditions prohibits tax credit research expenses involve creation human embryo research purposes destruction risk injury human embryo use stem cell prohibited purposes


Summary: Federal Ocean Acidification Research And Monitoring Act of 2009 or FOARAM Act - Defines "ocean acidification," for this Act, as the decrease in pH of the Earth's oceans and changes in ocean chemistry caused by chemical inputs from the atmosphere, including carbon dioxide. Requires that the Joint Subcommittee on Ocean Science and Technology of the National Science and Technology Council coordinate federal activities on ocean acidification and establish an interagency working group. Requires the Subcommittee to develop a strategic plan for federal ocean acidification research and monitoring that provides, among other things, for the development of adaptation and mitigation strategies. Directs the Secretary of Commerce, through the National Oceanic and Atmospheric Administration (NOAA), to enter into an agreement with the National Academy of Sciences (NAS) to review the plan. Directs the Secretary to establish and maintain an ocean acidification program in NOAA to conduct research, monitoring, and other activities, including: (1) providing grants for critical research projects exploring the ecosystem and socioeconomic impacts of ocean acidification; and (2) incorporating a competitive merit-based process for awarding grants that may be conducted jointly with other participating agencies or under the National Oceanographic Partnership Program. Requires the National Science Foundation (NSF) director to continue to carry out ocean acidification research supporting competitive, merit-based, peer-reviewed proposals for research and monitoring of ocean acidification and its impacts. Requires the administrator of the National Aeronautics and Space Administration (NASA) to ensure that space-based monitoring assets are used in as productive a manner as possible for the monitoring of ocean acidification and its impacts.

federal ocean acidification research monitoring act act defines ocean acidification act decrease earth oceans changes ocean chemistry caused chemical inputs atmosphere including carbon dioxide requires joint subcommittee ocean science_and_technology national_science_and_technology_council coordinate federal activities ocean acidification establish interagency_working_group requires subcommittee develop strategic plan federal ocean acidification research monitoring provides things development adaptation mitigation strategies directs secretary commerce national_oceanic_and_atmospheric_administration noaa enter agreement national_academy_of_sciences nas review plan directs secretary establish maintain ocean acidification program noaa conduct research monitoring activities including providing grants critical research projects exploring ecosystem socioeconomic impacts ocean acidification incorporating competitive merit based process awarding grants conducted jointly participating agencies national oceanographic partnership program requires national_science_foundation nsf director continue carry ocean acidification research supporting competitive merit based peer reviewed proposals research monitoring ocean acidification impacts requires administrator national_aeronautics_and_space_administration nasa ensure space based monitoring assets productive manner possible monitoring ocean acidification impacts


Summary: Melanie Blocker Stokes Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act or the Melanie Blocker Stokes MOTHERS Act - Encourages the Secretary of Health and Human Services to continue: (1) activities on postpartum depression; and (2) research to expand the understanding of the causes of, and treatments for, postpartum conditions. Expresses the sense of Congress that the Director of the National Institute of Mental Health may conduct a nationally representative longitudinal study of the relative mental health consequences for women of resolving a pregnancy in various ways.Amends the Public Health Service Act to authorize the Secretary to make grants for projects for the establishment, operation, and coordination of effective and cost-efficient systems for the delivery of essential services to individuals with a postpartum condition and their families. Directs the Secretary to ensure that such projects provide education and services with respect to the diagnosis and management of postpartum conditions. Authorizes such projects to include: (1) delivering or enhancing outpatient home-based health and support services; and (2) providing education to new mothers and their families about postpartum conditions to promote earlier diagnosis and treatment. Sets forth grant requirements. Directs the Secretary to study the benefits of screening for postpartum conditions.Prohibits the Secretary from utilizing amounts appropriated under this Act to carry out activities or programs that are duplicative of activities or programs that are already being carried out through the Department of Health and Human Services (HHS).

mom opportunity access health education research support postpartum depression act mothers act encourages secretary health_and_human_services continue activities postpartum depression research expand understanding causes treatments postpartum conditions expresses sense congress director national_institute_of_mental_health conduct nationally representative longitudinal study relative mental health consequences women resolving pregnancy ways amends public_health_service_act authorize secretary grants projects establishment operation coordination effective cost efficient systems delivery essential services individuals postpartum condition families directs secretary ensure projects provide education services respect diagnosis management postpartum conditions authorizes projects include delivering enhancing outpatient home based health support services providing education new mothers families postpartum conditions promote earlier diagnosis treatment sets forth grant requirements directs secretary study benefits screening postpartum conditions prohibits secretary utilizing amounts appropriated act carry activities programs duplicative activities programs carried department_of_health_and_human_services hhs


Summary: Pediatric Research Consortia Establishment Act - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH), acting through the Director of the National Institute of Child Health and Human Development, to award grants, contracts, or cooperative agreements for planning, establishing, and providing basic operating support for up to 20 national pediatric research consortia. Requires each such consortium to: (1) supplement, but not replace, the establishment of a comprehensive pediatric research portfolio; (2) conduct basic, clinical, behavioral, social, and translational research; and (3) conduct training and demonstration of advanced diagnostic and treatment methods relating to pediatrics.Requires the Director of NIH to provide for the coordination of information and ensure regular communication between consortia.

pediatric research consortia establishment act_-_amends public_health_service_act require director national_institutes_of_health nih acting director national institute child health human development award grants contracts cooperative agreements planning establishing providing basic operating support national pediatric research consortia requires consortium supplement replace establishment comprehensive pediatric research portfolio conduct basic clinical behavioral social translational research conduct training demonstration advanced diagnostic treatment methods relating pediatrics requires director nih provide coordination information ensure regular communication consortia